Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03644212 · ClinicalTrials.gov registry record · Phase 4
Vitamin D Increases Serum Levels of the Soluble Receptor for Advanced Glycation End Products in Women With PCOS
A Phase 4 study of Vitamin D Deficiency and Polycystic Ovary Syndrome, sponsored by Maimonides Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 79
- Enrollment target
- 1
- Study location
NCT03644212: Completed Phase 4 study of Vitamin D Deficiency and Polycystic Ovary Syndrome, sponsored by Maimonides Medical Center.
NCT03644212 is a Phase 4 study of Vitamin D Deficiency and Polycystic Ovary Syndrome that has completed, run by Maimonides Medical Center. The registered enrollment target is 79 participants, below the 274-participant average among 48 other Vitamin D Deficiency trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03644212, a Phase 4 study of Vitamin D Deficiency and Polycystic Ovary Syndrome, has completed, sponsored by Maimonides Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 79 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to investigate the mechanism that explain the beneficial clinical effect of vitamin D treatment in women with PCOS.
Primary Outcome
AMH measured by serum analysis
Conditions Studied
Interventions
- DRUG Vitamin D3
Study Locations (1)
New York
- Maimonides Medical Center, OBGYN clinic - Brooklyn
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 79 participants |
| Start Date | 2012-07 |
| Est. Completion | 2013-10 |
| Phase | Phase 4 |
What the finished NCT03644212 record still lists
NCT03644212 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 79 participants, a relatively small participant target, below the 274-participant average among 48 other Vitamin D Deficiency trials with a reported enrollment target (71% lower).
The record links to 2 conditions, with Vitamin D Deficiency appearing as the primary indexed condition, and to 1 intervention - of which Vitamin D3 is the first listed.
NCT03644212 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT03644212 about?
NCT03644212 is a clinical study titled "Vitamin D Increases Serum Levels of the Soluble Receptor for Advanced Glycation End Products in Women With PCOS". The purpose of this study is to investigate the mechanism that explain the beneficial clinical effect of vitamin D treatment in women with PCOS.
What is the current status of trial NCT03644212?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 79 participants. The study started on 2012-07. Estimated completion is 2013-10.
What conditions does trial NCT03644212 study?
This clinical trial studies the following conditions: Vitamin D Deficiency, Polycystic Ovary Syndrome.
What interventions are being tested in trial NCT03644212?
The interventions under investigation include: Vitamin D3 (DRUG).
Who is sponsoring clinical trial NCT03644212?
This trial is sponsored by Maimonides Medical Center, which has 39 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03644212 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vitamin D Deficiency
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03644212's enrollment target sits among peer trials
79 22nd of 48 higher than 27 of 48 other Vitamin D Deficiency trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Vitamin D Deficiency trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Preoperative Correction of Vitamin D Deficiency in Total Joint Arthroplasty (TJA)
ACTIVE NOT RECRUITING · Phase 4
-
Vitamin D Supplementation in the Prevention and Mitigation of COVID-19 Infection
ACTIVE NOT RECRUITING · Phase 4
-
Does Treatment of Hypovitaminosis D Increase Calcium Absorption?
COMPLETED · Phase 4
-
A Randomized Phase IV Control Trial of Single High Dose Oral Vitamin D3 in Pediatric Patients Undergoing HSCT
COMPLETED · Phase 4
-
Characterization of Hyperparathyroidism and Vitamin D Deficiency in Obesity
COMPLETED · Phase 4
-
High Dose Interval Vitamin D Supplementation in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05798897 · 79 participants · Phase 1
Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma
- NCT06042439 · 79 participants · NA
AM vs PM Exercise Training
- NCT06223555 · 79 participants · NA
Variability In Mixed Meal Tests: Fixed Versus Adjusted to Energy Needs Caloric Dose
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia